MindWalk Holdings (HYFT) Times Interest Earned (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Times Interest Earned of $0.0 for Q2 2026, up 164.85% year-over-year from $0.0 in Q2 2025, and up 164.85% quarter-over-quarter from -$0.0 in Q2 2025.
Powered by 
Analysis
MindWalk Holdings (HYFT) Times Interest Earned (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Times Interest Earned for 7 consecutive years, with $0.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Times Interest Earned rose 164.85% year-over-year to $0.0; the TTM figure through Apr 2026 stood at $0.02 (up 100.15% YoY), while the FY2026 annual figure was -$0.08, down 226546.53% from the prior year.
- Times Interest Earned advanced to $0.0 in Q2 2026 per HYFT's latest filing, from -$0.0 in the prior quarter.
- Across five years, Times Interest Earned topped out at $30.13 in Q2 2023 and bottomed at -$127.49 in Q3 2022.
- Historically, Times Interest Earned has averaged -$25.27 across 5 years, with a median of -$2.19 in 2022.
- Annual changes were most pronounced in 2022 — Times Interest Earned plunged 290494.35% — and 2023, when it jumped 788.03%.
- MindWalk Holdings' Times Interest Earned stood at -$0.0 in 2022, then soared by 101245669.65% to $30.13 in 2023, then sank by 284.37% to -$55.55 in 2024, then surged by 100.0% to -$0.0 in 2025, then jumped by 164.85% to $0.0 in 2026.
- Business Quant data shows HYFT's Times Interest Earned at $0.0 in Q2 2026, -$0.0 in Q2 2025, and -$55.55 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | MindWalk Holdings | 61.22 Mn | 52.95 Mn | 1.82 Mn | 865.80 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 865.80 |
| Apr 30, 2025 | 4,390.25 |
| Jan 31, 2025 | 8,286.33 |
| Oct 31, 2024 | 1,351.33 |
| Apr 30, 2024 | 5,582.25 |
| Jan 31, 2024 | 668.00 |
| Oct 31, 2023 | 1,154.41 |
| Jul 31, 2023 | 1.37 Mn |
| Apr 30, 2023 | 225.04 |
| Oct 31, 2022 | 3.91 |
| Jul 31, 2022 | -32.30 |
| Apr 30, 2022 | 6.36 |
| Jan 31, 2022 | -14.61 |
| Oct 31, 2021 | -17.48 |
| Jul 31, 2021 | -21.26 |
| Apr 30, 2021 | -16.65 |
| Jan 31, 2021 | -5.84 |
| Oct 31, 2020 | 95.88 |